Gland Pharma informs about press release

15 Nov 2023 Evaluate
Gland Pharma has informed that it enclosed attached press release on ‘Gland Pharma receives tentative approval from the United States Food and Drug Administration (US FDA) for Angiotensin II for Injection, 2.5 mg/ ml Single-Dose Vial’

The above information is a part of company’s filings submitted to BSE.


Gland Pharma Share Price

1802.00 22.85 (1.28%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.